FIELD: medicine.
SUBSTANCE: induction standard therapeutic course is followed by determining the blood serum lactoferrin concentration, and if the derived values exceed 874.7±21.6 ng/ml, the absence of a clinical remission of ulcerative colitis is stated.
EFFECT: more accurate evaluation of the clinical effectiveness in ulcerative colitis in achieving the clinical remission following the four-week therapeutic course.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INDIVIDUAL SENSITIVITY TO PREPARATIONS OF 5-AMINOSALYCILIC ACID (5-ASA) IN PATIENTS WITH ULCEROUS COLITIS | 2005 |
|
RU2287819C1 |
METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2009 |
|
RU2394571C1 |
METHOD FOR TREATING INFLAMMATORY DISEASES OF TERMINAL COLON | 2022 |
|
RU2807235C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING RECURRENT INFLAMMATORY INTESTINAL DISEASES | 2012 |
|
RU2517069C1 |
METHOD FOR DIAGNOSING DEGREE OF ACTIVITY OF ULCERATIVE COLITIS | 2023 |
|
RU2821756C1 |
METHOD OF TREATING CYTOMEGALOVIRUS INFECTION | 2013 |
|
RU2540474C2 |
METHOD FOR TREATING ULCERATIVE COLITIS | 2000 |
|
RU2165758C1 |
METHOD FOR INTRAPERITONEAL APPLICATION OF MEDICAL OZONE FOR TREATING ULCERATIVE COLITIS | 2021 |
|
RU2782488C1 |
METHOD OF TREATING PATIENTS WITH ULCERATIVE COLITIS | 2009 |
|
RU2419443C1 |
MEDICINE FOR IMMUNOCOMPETENCE ENHANCEMENT | 2007 |
|
RU2349335C2 |
Authors
Dates
2014-01-20—Published
2012-10-08—Filed